Matches 1 - 50 out of 384 1 2 3 4 5 6 7 8 >


Match Document Document Title
US20140221906 PATCH SYSTEM FOR THE TREATMENT OF WARTS AND METHOD FOR SAME  
The present system and method relates in general to treating warts using a triple combination of therapies contained within a kit. The therapies are easy for a patient to self-apply, eliminating...
US20150071992 CONCENTRATED, INHALABLE ANTIBIOTIC FORMULATION  
A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The...
US20110015134 Method of treatment for early stage cancer  
This patent describes a method and materials to treat cancer diagnosed at an early stage, particularly breast cancer. It considers that metastatic breast cancer growth includes periods of...
US20110318434 Acne Vulgaris Treatment Regimen  
An improved method, formulation and kit for the treatment of acne vulgaris are disclosed. The formulation is effective in inhibiting or killing the Proprionibacterium microorganism without...
US20130289005 Acne Vulgaris Treatment Regimen  
A kit for treatment of acne vulgaris, said formulation of the kit effectively inhibiting or killing Proprionibacterium without antibiotics. A preferred formulation alleviates the four pathogenic...
US20130316024 COSMETIC KIT AND USE FOR IMPROVING THE APPEARANCE OF THE SKIN  
A cosmetic kit and the use thereof for improving the appearance of the skin is described. Further described, is the prevention and/or controlling of cellulite or the orange peel syndrome and/or...
US20110008413 Compositions and Methods of Topical Drug Delivery for the Treatment of Carpal Tunnel Syndrome  
The present invention generally relates to transdermal drug delivery systems. More particularly, the present invention provides compositions and transdermal drug delivery systems for the treatment...
US20140329781 METHODS FOR TREATING CARDIOVASCULAR DISORDER  
The present invention relates to a once-a-day therapeutically synergistic pharmaceutical dosage form for treatment of cardiovascular disorders, wherein the dosage form comprises a fixed dose...
US20110038927 CONTROLLED RELEASE HYDROCODONE FORMULATIONS  
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
US20150037318 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FLUPIRTINE  
This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an...
US20110294763 TRANSDERMAL DELIVERY OF DICOLFENAC, CARBAMAZEPINE AND BENZYDAMINE  
The invention discloses solutions of diclofenac, carbamazepine and benzydamine, at therapeutically desirable concentrations and the solutions stable for extended periods of time at room temperature.
US20120021049 Single Daily Dosage Form for Prevention and Treatment of Metabolic Syndrome  
The present invention is in the fields of medicine, pharmaceuticals, nutraceuticals, endocrinology and cardiology. The invention provides compositions comprising a statin, an inhibitor of the...
US20140017226 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FAMPRIDINE  
This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject fampridine as an...
US20130259856 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND DIMETHYL FUMARATE  
This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an...
US20110021447 ACNE TREATMENT COMPOSITION AND METHODS FOR USING  
An acne treatment composition is provided according to the present invention. The acne treatment composition includes an effective amount of an anti-acne component to provide anti-acne properties...
US20120157415 New Crystalline Form of Pemirolast  
There is provided a hemihydrate form of the sodium salt of pemirolast.
US20130266651 LONG ACTING DUAL RELEASE PRODUCT CONTAINING CARBINOXAMINE AND PSEUDOEPHEDRINE  
Provided are oral dosage forms that contain carbinoxamine in an immediate release format, and pseudoephedrine in a prolonged release format. The biphasic oral dosage forms may also contain other...
US20110268798 ORALLY DISNTEGRATING TABLETS FOR THE TREATMENT OF PAIN  
An orally disintegrating tablet comprising acetylsalicylic acid, acetaminophen and caffeine and one or more pharmaceutically acceptable excipients.
US20120053157 METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM  
The present invention relates to a method of ameliorating the drawbacks of anti-platelet drug named clopidogrel. The method of the present invention comprises administration of an...
US20140193346 HEALTH SUPPLEMENT  
Herbal composition and method for the treatment of inflammatory pain associated with tendonitis, bursitis, arthritis, carpal tunnel syndrome, tennis elbow, plantar fasciitis, sports injuries,...
US20140079685 METHOD AND COMPOSITION FOR TREATING A SEROTONIN RECEPTOR-MEDIATED CONDITION  
A method and composition for treating serotonin receptor-mediated conditions.
US20150045332 Novel Sphingosine 1-Phosphate Receptor Antagonists  
The present invention relates to sphingosine-1-phosphate (S1P) receptors and compounds of the general formula: that are useful in the treatment and prevention of conditions associated with such...
US20110086094 CAPSULE FOR THE PREVENTION OF CARDIOVASCULAR DISEASES  
The invention relates to a capsule for the prevention of cardiovascular diseases which comprises coated tablets of acetylsalicylic acid, coated tablets of simvastatin or pravastatin, and coated...
US20150072005 ASPIRIN FORMULATION FOR INCREASED EFFICACY  
Provided are methods for enhancing the efficacy of aspirin. Also provided are methods for reducing pain or preventing or treating heart attack, stroke or blood clot in a subject in need thereof....
US20140348957 Therapeutic and Method of Use  
The present invention is a compound comprising an NSAID portion and at least one of a progestin portion and a progesterone portion. The compound may take for instance the form of a pill or pellet...
US20130095095 METHOD FOR TREATING THROMBOTIC DISORDERS USING QUERCETIN-CONTAINING COMPOSITIONS  
A method for treating thrombotic disorders using a composition containing quercetin, together with one or more of vitamin B3, vitamin C, and folic acid. Also disclosed is a method of improving the...
US20090117054 SUBLINGUAL SPRAY FOR THE TREATMENT OF PAIN  
This invention relates to a spray for sublingual administration, used in the treatment and management of pain, especially acute pain. Also provided are methods of treatment and management of pain,...
US20120121567 OPHTHALMIC SOLUTION FOR PROTECTING INTERNAL STRUCTURES OF THE EYEBALL AGAINST UV-A RAYS OR FOR THE TREATMENT OF KERATOCONUS WITH A TRANS-EPITHELIAL CROSS-LINKING TECHNIQUE  
An ophthalmic solution containing riboflavin and at least a compound chosen in the group composed of essential and conditionally essential amino acids, coenzyme Q, L-proline, glycine, lysine...
US20110263545 HEPATOPROTECTANT ACETAMINOPHEN MUTUAL PRODRUGS  
The present invention provides hepatoprotectant acetaminophen mutual prodrugs, which have an acetaminophen moiety covalently linked to a second moiety that may act as a hepatoprotectant against...
US20130165418 OPIOID AGONIST/OPIOID ANTAGONIST/ACETAMINOPHEN COMBINATIONS  
The invention is directed in part to oral dosage forms comprising a combination of an opioid agonist, acetaminophen and an orally active opioid antagonist, the opioid antagonist being included in...
US20120164139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders  
Provided herein are methods of treating gastrointestinal motility disorders by targeting the dopamine 3 receptor (D3R). A D3R agonist is administered to a subject to decrease gastrointestinal...
US20120141467 Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma  
Provided herein is a method for treating a tracheo-bronchial-alveolar tract disease in a subject in need thereof, the method comprising the step of administering to a subject in need of such...
US20100305075 COMPOSITION AND METHOD OF TREATING HEARING LOSS  
A composition for treating hearing loss includes components that function through different biological mechanisms to provide an additive effect that is greater than the effect of the individual...
US20140227356 COMPOSITE FORMULATION COMPRISING A TABLET ENCAPSULATED IN A HARD CAPSULE  
The present invention relates to a hard capsule composite formulation comprising a capsule having a hemispherical closure at each end and an interior space; and one or more tablets encapsulated in...
US20120230984 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds  
The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms...
US20110151024 Compositions and Methods for Preventing Migraines  
The present invention relates to compositions and methods for preventing migraines. The migraine prophylaxis composition is a single dosage form comprising at least one form of elemental magnesium...
US20140303074 Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription  
The present disclosure provides methods of reducing immunodeficiency virus transcription, involving use of diflunisal or an active ester thereof. The disclosure also provides methods of treating...
US20130210720 TREATMENT OF HEART FAILURE  
The invention relates to perhexiline, or a pharmaceutically acceptable salt thereof, for use in the treatment of heart failure, as well as to a method for treating heart failure, which comprises...
US20130210719 TREATMENT OF HEART FAILURE  
The invention relates to perhexiline, or a pharmaceutically acceptable salt thereof, for use in the treatment of heart failure, as well as to a method for treating heart failure, which comprises...
US20140057883 TREATMENT OF CROHN'S DISEASE WITH LAQUINIMOD  
This application provides for a method of treating a subject suffering from Crohn's disease, the method comprising periodically administering to the subject an amount of laquinimod or...
US20110027219 Treatment of Crohn's disease with laquinimod  
This application provides for a method of treating a subject suffering from Crohn's disease, the method comprising periodically administering to the subject an amount of laquinimod or...
US20140220124 COMBINATION TABLET WITH CHEWABLE OUTER LAYER  
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa...
US20130189361 COMBINATION TABLET WITH CHEWABLE OUTER LAYER  
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa...
US20070232574 2-Oxothiazolidine 4-Carboxylic acid compounds for promoting desquamation of the skin  
2-oxothiazolidine-4-carboxylic acid compounds having the structural formula (I): are suited for promoting desquamation of the skin and/or stimulating epidermal renewal and/or combating aging of...
US20140147505 SOLID PHARMACEUTICAL DOSAGE FORM OF TICAGRELOR  
The present invention relates to a solid pharmaceutical dosage form comprising ticagrelor as pharmaceutically active ingredient, to certain particles of ticagrelor and to processes of preparing...
US20130028938 SOLID PHARMACEUTICAL DOSAGE FORM  
The present invention relates to a solid pharmaceutical dosage form comprising ticagrelor as pharmaceutically active ingredient, to certain particles of ticagrelor and to processes of preparing...
US20150202162 COLONIC DRUG DELIVERY FORMULATION  
A delayed release coating comprising a mixture of a first material selected from starch; amylose; amylopectin; chitosan; chondroitin sulfate; cyclodextrin; dextran; pullulan; carrageenan;...
US20130157985 PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES  
The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain...
US20110082118 Onychomycosis Treatment Delivery System  
A topical treatment for onychomycosis and Tinea pedis comprising a delivery system further comprising at least one hydroxy acid agent having a pH-pKa value of 0.5 or greater and at least one...
US20110105441 Stable Orally Disintegrating Tablets Having Low Superdisintegrant  
The invention is directed to the functionality and performance of superdisintegrants in orally disintegrating tablets (ODT). The invention can be an aged direct compression ODT having between...

Matches 1 - 50 out of 384 1 2 3 4 5 6 7 8 >